Keywords: استنت بدون فلز; biodegradable polymers; bioresorbable vascular scaffold; bleeding; drug-eluting stent; percutaneous coronary intervention; stent restenosis; stent thrombosis; 1G-DES; first-generation drug-eluting stent(s); 2G-DES; second-generation drug-eluting stent(s);
مقالات ISI استنت بدون فلز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: استنت بدون فلز; AMI; acute myocardial infarction; BMS; bare-metal stent(s); DES; drug-eluting stent(s); FDA; Food and Drug Administration; PCI; percutaneous coronary intervention;
Keywords: استنت بدون فلز; bioresorbable vascular scaffolds; complex coronary lesions; long coronary lesions; vascular reparative therapy; BMS; bare-metal stent(s); BVS; bioresorbable vascular scaffold(s); CI; confidence interval; DES; drug-eluting stent(s); HR; hazard ratio; MI; m
Keywords: استنت بدون فلز; complex lesions; dual antiplatelet therapy; dual antiplatelet therapy score; percutaneous coronary intervention; BMS; bare-metal stent(s); DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); MACCE; major adverse cardiovascular and cerebrovascular
Keywords: استنت بدون فلز; biodegradable polymer; drug-eluting stent(s); durable polymer; meta-analysis; BMS; bare-metal stent(s); BP-DES; biodegradable polymer drug-eluting stent(s); CI; confidence interval; DAPT; dual-antiplatelet therapy; DES; drug-eluting stent(s); DP-DES; dura
Keywords: استنت بدون فلز; bare-metal stent(s); bioresorbable vascular scaffolds; drug-eluting stent(s); percutaneous coronary intervention; stent thrombosisBMS, bare-metal stent(s); BP-BES, biodegradable polymer biolimus A9-eluting stent(s); BP-EES, biodegradable polymer everolimu
Keywords: استنت بدون فلز; angina pectoris; coronary artery bypass; coronary artery disease; guideline-directed medical therapy; percutaneous coronary intervention; ACS; acute coronary syndrome; BMS; bare-metal stent(s); CABG; coronary artery bypass graft; CAD; coronary artery dis
Keywords: استنت بدون فلز; bare-metal stent(s); drug-eluting stent(s); meta-analysis; stent thrombosisBES, biolimus-eluting stent(s); BMS, bare-metal stent(s); CI, credible interval; CoCr-EES, cobalt-chromium everolimus-eluting stent(s); DES, drug-eluting stent(s); HR, hazard ratio
Keywords: استنت بدون فلز; antiplatelet therapy; aspirin; coronary stent; drug-eluting stent; P2Y12 inhibitors; ACS; acute coronary syndrome(s); BMS; bare-metal stent(s); CAD; coronary artery disease; DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); L-DAPT; long duratio
Keywords: استنت بدون فلز; diabetes mellitus; drug-eluting stent(s); prognosis; ACC; American College of Cardiology; AHA; American Heart Association; BMS; bare-metal stent(s); CABG; coronary artery bypass grafting; CI; confidence interval; DES; drug-eluting stent(s); DM; diabetes m
Keywords: استنت بدون فلز; bare-metal stent(s); drug-eluting stent(s); meta-analysis; stent thrombosisBP, bioabsorbable polymers; BES, biolimus-eluting stent(s); CI, credible interval; CoCr-EES, cobalt-chromium everolimus-eluting stent(s); DP, durable polymers; OR, odds ratio; PC-Z
Keywords: استنت بدون فلز; acute coronary syndrome(s); bare-metal stent(s); drug-eluting stent(s); early stent thrombosis; histopathology; ACS; acute coronary syndrome(s); BMS; bare-metal stent(s); DES; drug-eluting stent(s); GEE; generalized estimating equation; IVUS; intravascula
Keywords: استنت بدون فلز; bare-metal stent(s); drug-eluting stent(s); stent thrombosis; ARC; Academic Research Consortium; BMS; bare-metal stent(s); CoCr-EES; cobalt-chromium everolimus-eluting stent(s); DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); FDA; Food and D
Elective Coronary Revascularization Procedures in Patients With Stable Coronary Artery Disease
Keywords: استنت بدون فلز; coronary artery disease; elective revascularization; follow-up; outcome; outpatient; ACE; angiotensin-converting enzyme; ARB; angiotensin receptor blocker; BMS; bare-metal stent(s); CABG; coronary artery bypass; CAD; coronary artery disease; CI; confidenc
First-in-Human Closed-Chest Transcatheter Superior Cavopulmonary Anastomosis
Keywords: استنت بدون فلز; adult congenital heart disease; catheterization; Glenn shunt; image-guided intervention; single ventricle; transcatheter electrosurgery; 3D; 3-dimensional; BMS; bare-metal stent(s); CT; computed tomography; PA; pulmonary artery; SVC; superior vena cava;
9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System
Keywords: استنت بدون فلز; restenosis; stent(s); thrombosis; BMS; bare-metal stent(s); CI; confidence interval; CKMB; creatine kinase-MB; DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); LL; lumen loss; MI; myocardial infarction; PzF; Polyzene-F; QCA; quantitative cor
The SABRE Trial (Sirolimus Angioplasty Balloon for Coronary In-Stent Restenosis)
Keywords: استنت بدون فلز; drug-eluting balloon; extended release; in-stent restenosis; porous angioplasty balloon; sirolimus nanoparticle; BMS; bare-metal stent(s); DES; drug-eluting stent(s); ISR; in-stent restenosis; ITT; intention to treat; LLL; late lumen loss; MACE; major adv
First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent
Keywords: استنت بدون فلز; drug-eluting stent(s); drug-filled stent(s); percutaneous coronary intervention; polymer-free stent; BMS; bare-metal stent(s); DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); DFS; drug-filled stent(s); IVUS; intravascular ultrasound; MI; myoc
Should We Still Have Bare-Metal Stents Available in Our Catheterization Laboratory?
Keywords: استنت بدون فلز; drug-eluting stent; dual antiplatelet therapy; high bleeding risk patients; in-stent restenosis; stent thrombogenicity; stent thrombosis; BA9; biolimus A9; BMS; bare-metal stent(s); DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); EES; everoli
Mechanisms of Very Late Bioresorbable Scaffold Thrombosis
Keywords: استنت بدون فلز; bioresorbable coronary scaffolds; coronary artery disease; stent; stent thrombosis; 3D; 3-dimensional; ACS; acute coronary syndrome(s); BMS; bare-metal stent(s); BVS; bioresorbable vascular scaffold; DAPT; dual-antiplatelet therapy; DES; drug-eluting sten
Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 12-Month Results
Keywords: استنت بدون فلز; drug-eluting stent(s); paclitaxel-eluting stent(s); peripheral artery disease; peripheral vascular disease; popliteal artery; superficial femoral artery; ABI; ankle brachial index; BMS; bare-metal stent(s); CLI; critical limb ischemia; DCB; drug-coated ba
Left Main Stenting in Comparison With Surgical Revascularization: 10-Year Outcomes of the (Left Main Coronary Artery Stenting) LE MANS Trial
Keywords: استنت بدون فلز; coronary artery bypass surgery; left main disease; stenting; ten-year outcome; BMS; bare-metal stent(s); CABG; coronary artery bypass grafting; DES; drug-eluting stent(s); LVEF; left ventricular ejection fraction; MACCE; major adverse cardiac and cerebro
Risk Associated With Surgery Within 12 Months After Coronary Drug-Eluting Stent Implantation
Keywords: استنت بدون فلز; coronary artery disease; epidemiology; interventional cardiology; noncardiac surgery; ACS; acute coronary syndrome; BMS; bare-metal stent(s); CI; confidence interval; DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); DNPR; Danish National Patie
Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis
Keywords: استنت بدون فلز; cardiovascular disease; end-stage renal disease; epidemiology; hemodialysis; ischemic heart disease; renal insufficiency; BMS; bare-metal stent(s); CI; confidence interval; DES; drug-eluting stent(s); ESRD; end-stage renal disease; HR; hazard ratio; IPTW
Histopathological Differential Diagnosis of Optical Coherence Tomographic Image Interpretation After Stenting
Keywords: استنت بدون فلز; coregistration; neoatherosclerosis; OCT; OFDI; stent failure; stent healing; BMS; bare-metal stent(s); DES; drug-eluting stent(s); OCT; optical coherence tomographic; OFDI; optical frequency-domain imaging; PLIA; peristrut low attenuation; SMC; smooth mus
A 2-year follow-up of a randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels the BELLO study
Keywords: استنت بدون فلز; BMS; bare-metal stent(s); DEB; drug-eluting balloon(s); DES; drug-eluting stent(s); ECG; electrocardiogram; ISR; in-stent restenosis; MACE; major adverse cardiac event; MI; myocardial infarction; PES; paclitaxel-eluting stents; RCT; randomized controlled
Clinical Impact of OCT Findings During PCI: The CLI-OPCI II Study
Keywords: استنت بدون فلز; clinical outcome; optical coherence tomography; percutaneous coronary intervention; registry; BMS; bare-metal stent(s); CI; confidence interval; DES; drug-eluting stent(s); HR; hazard ratio; IQR; interquartile range; IVUS; intravascular ultrasound; MACE;
Comparison of Sirolimus-Eluting Stenting With Minimally Invasive Bypass Surgery for Stenosis of the Left Anterior Descending Coronary Artery: 7-Year Follow-Up of a Randomized Trial
Keywords: استنت بدون فلز; bypass surgery; drug-eluting stent; left anterior descending artery; long-term follow-up; percutaneous coronary intervention; BMS; bare-metal stent(s); CI; confidence interval(s); DES; drug-eluting stent(s); HR; hazard ratio(s); IQR; interquartile range;
Incidence and Clinical Impact of Stent Fracture After PROMUS Element Platinum Chromium Everolimus-Eluting Stent Implantation
Keywords: استنت بدون فلز; drug-eluting stent fracture; platinum-chromium everolimus-eluting stent; target lesion revascularization; BES; biolimus-eluting stent; BMS; bare-metal stent(s); CoCr-EES; cobalt chromium everolimus-eluting stent; DES; drug-eluting stent(s); ISR; in-stent
6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin: The Randomized, Multicenter ITALIC Trial
Keywords: استنت بدون فلز; double antiplatelet duration; percutaneous coronary angioplasty; ACS; acute coronary syndrome(s); BMS; bare-metal stent(s); DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); MI; myocardial infarction; PCI; percutaneous coronary intervention;
Zotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent Candidates
Keywords: استنت بدون فلز; drug-eluting stent(s); dual-antiplatelet therapy; high bleeding risk; high thrombotic risk; zotarolimus-eluting stent(s); BMS; bare-metal stent(s); CI; confidence interval; DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); HR; hazard ratio; IQR
Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial
Keywords: استنت بدون فلز; aspirin; atrial fibrillation; clopidogrel; percutaneous coronary intervention; vitamin K antagonist; BARC; Bleeding Academic Research Consortium; BMS; bare-metal stent(s); DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); MI; myocardial infarct
Acute Thrombogenicity of a Durable Polymer Everolimus-Eluting Stent Relative to Contemporary Drug-Eluting Stents With Biodegradable Polymer Coatings Assessed Ex Vivo in a Swine Shunt Model
Keywords: استنت بدون فلز; coronary disease; pathology; stents; thrombosis; BES; biolimus-eluting stent(s); BMS; bare-metal stent(s); CI; confidence interval; DAPI; 4â²,6-diamindino-2-phenylindole; DES; drug-eluting stent(s); EES; everolimus-eluting stent(s); SEM; scanning electro
Reducing In-Stent Restenosis: Therapeutic Manipulation of miRNA in Vascular Remodeling and Inflammation
Keywords: استنت بدون فلز; late stent thrombosis; miRNAÂ stem loop; neointima; smooth muscle cell; BMDM; bone marrow-derived macrophages; BMS; bare-metal stent(s); CD; cluster of differentiation; DES; drug-eluting stent(s); IL; interleukin; ISR; in-stent restenosis; KO; knockout;
Mitigating the Risk of Early Stent Thrombosisâ
Keywords: استنت بدون فلز; acute coronary syndrome(s); bare-metal stent(s); drug-eluting stent(s); early stent thrombosis; histopathology;
A Prospective Randomized Trial of Everolimus-Eluting Stents Versus Bare-Metal Stents in Octogenarians : The XIMA Trial (Xience or Vision Stents for the Management of Angina in the Elderly)
Keywords: استنت بدون فلز; bare-metal stent(s); drug-eluting stent(s); octogenariansBMS, bare-metal stent(s); CVA, cerebrovascular accident; DAPT, dual antiplatelet therapy; DES, drug-eluting stent(s); MI, myocardial infarction; PCI, percutaneous coronary intervention; TVR, target
A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon Versus Paclitaxel-Eluting Stent for the Treatment of Drug-Eluting Stent In-Stent Restenosis: Results From the PEPCAD China ISR Trial
Keywords: استنت بدون فلز; in-stent restenosis; paclitaxel-coated balloon(s); paclitaxel-eluting stent(s); BMS; bare-metal stent(s); CI; confidence interval(s); DES; drug-eluting stent(s); ISR; in-stent restenosis; LLL; late lumen loss; MLD; minimal lumen diameter(s); PCB; paclitax
Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents in Patients With ST Elevation Myocardial Infarction: RACES-MI Trial
Keywords: استنت بدون فلز; everolimus-eluting stent(s); primary angioplasty; sirolimus-eluting stent(s); stent thrombosis; ST-segment elevation myocardial infarction; BMS; bare-metal stent(s); CI; confidence interval; DES; drug-eluting stent(s); EES; everolimus-eluting stent(s); HR
Outcomes After Percutaneous Coronary Intervention With Stents in Patients Treated With Thoracic External Beam Radiation for Cancer
Keywords: استنت بدون فلز; cancer; coronary artery stent; malignancy; radiation therapy; restenosis; survivorship; BMS; bare-metal stent(s); CAD; coronary artery disease; DES; drug-eluting stent(s); EBRT; external beam radiation therapy; IQR; interquartile range; MI; myocardial inf
Stent Thrombosis in New-Generation Drug-Eluting Stents in Patients With STEMI Undergoing Primary PCI: A Report From SCAAR
Keywords: استنت بدون فلز; drug-eluting stent(s); percutaneous coronary intervention; ST-segment elevation myocardial infarction; BMS; bare-metal stent(s); CI; confidence interval; DAPT; dual-antiplatelet therapy; DES; drug-eluting stent(s); HR; hazard ratio; n-DES; new-generation
Scaffold and Edge Vascular Response Following Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffold: A 3-Year Serial Optical Coherence Tomography Study
Keywords: استنت بدون فلز; Absorb BVS; bioresorbable scaffold; edge vascular response; in-scaffold vascular response; optical coherence tomography; BMS; bare-metal stent(s); BRS; bioresorbable scaffold(s); BVS; bioresorbable vascular scaffold(s); CI; confidence interval; DES; drug-
Two-Year Outcomes After First- or Second-Generation Drug-Eluting or Bare-Metal Stent Implantation in All-Comer Patients Undergoing Percutaneous Coronary Intervention : A Pre-Specified Analysis From the PRODIGY Study (PROlonging Dual Antiplatelet Treatment
Keywords: استنت بدون فلز; all-comer randomized clinical trial; bare-metal stent(s); everolimus-eluting stent(s); paclitaxel-eluting stent(s); zotarolimus-eluting stent(s)BMS, bare-metal stent(s); CI, confidence interval; CK-MB, creatine kinase myocardial band; DES, drug-eluting st
1-Year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis of the ABSORB and the SPIRIT Trials
Keywords: استنت بدون فلز; bioresorbable scaffold; coronary artery disease; diabetes mellitus; drug-eluting stent; ARC; Academic Research Consortium; BMS; bare-metal stent(s); BVS; bioresorbable vascular scaffold; CAD; coronary artery disease; DES; drug-eluting stent(s); DoCE; devi
Drug Delivering Technology for Endovascular Management of Infrainguinal Peripheral Artery Disease
Keywords: استنت بدون فلز; drug-coated stents; drug-coated balloons; peripheral artery disease; review; BMS; bare-metal stent(s); BTK; below-the-knee; CLI; critical limb ischemia; DCB; drug-coated balloon(s); DCS; drug-coated stent(s); PAD; peripheral artery disease; PES; paclitaxe
Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions: 2-Year Follow-Up From the Zilver PTX Randomized and Single-Arm Clinical Studies
Keywords: استنت بدون فلز; angioplasty; drug-eluting stent(s); paclitaxel-eluting stent(s); peripheral arterial disease; ABI; ankle-brachial index; BMS; bare-metal stent(s); DES; drug-eluting stent(s); EFS; event-free survival; PTA; percutaneous transluminal angioplasty; SFA; super
Long-Term Outcome After Drug-Eluting Versus Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction : 5 Years Follow-Up From the Randomized DEDICATION Trial (Drug Elution and Distal Protection in Acute Myocardial Infarcti
Keywords: استنت بدون فلز; bare-metal stent(s); drug-eluting stent(s); myocardial infarction; paclitaxel; percutaneous coronary intervention; sirolimus; stent thrombosis; zotarolimusBMS, bare-metal stent(s); DES, drug-eluting stent(s); MACE, major adverse cardiac event(s); PCI, per
Colchicine Treatment for the Prevention of Bare-Metal Stent Restenosis in Diabetic Patients
Keywords: استنت بدون فلز; bare-metal stent(s); diabetes; hyperplasia; in-stent restenosis; intravascular ultrasound; neointimaangio-ISR, angiographic in-stent restenosis; BMS, bare-metal stent(s); CI, confidence interval; ISR, in-stent restenosis; IVUS, intravascular ultrasound; I
Risk of Stent Thrombosis Among Bare-Metal Stents, First-Generation Drug-Eluting Stents, and Second-Generation Drug-Eluting Stents : Results From a Registry of 18,334 Patients
Keywords: استنت بدون فلز; bare-metal stent(s); drug-eluting stent(s); stent thrombosisBMS, bare-metal stent(s); CI, confidence interval; DES, drug-eluting stent(s); G1-DES, first-generation drug-eluting stent(s); G2-DES, second-generation drug-eluting stent(s); OR, odds ratio; STE
Clinical Outcomes With Drug-Eluting and Bare-Metal Stents in Patients With ST-Segment Elevation Myocardial Infarction : Evidence From a Comprehensive Network Meta-Analysis
Keywords: استنت بدون فلز; bare-metal stent(s); drug-eluting stent(s); meta-analysis; stent thrombosisBMS, bare-metal stent(s); CoCr-EES, cobalt-chromium everolimus-eluting stent(s); DES, drug-eluting stent(s); PES, paclitaxel-eluting stent(s); PCI, percutaneous coronary interventi
Drug-Eluting Stents for Revascularization of Infrapopliteal Arteries : Updated Meta-Analysis of Randomized Trials
Keywords: استنت بدون فلز; bare-metal stent(s); drug-eluting stent(s); infrapopliteal artery; meta-analysis; plain angioplastyARR, absolute risk reduction; BMS, bare-metal stent(s); CI, confidence interval; CLI, critical limb ischemia; DAPT, dual antiplatelet therapy; DES, drug-elu